Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

Author： Clements-Mann M.L.   Makhene M.K.   Mrukowicz J.   Wright P.F.   Hoshino Y.   Midthun K.   Sperber E.   Karron R.   Kapikian A.Z.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.20, 1999-06, pp. : 2715-2725

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants

By Clements-Mann M.L.   Dudas R.   Hoshino Y.   Nehring P.   Sperber E.   Wagner M.   Stephens I.   Karron R.   Deforest A.   Kapikian A.Z.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4676-4684

Elsevier

Access to resources Recommend Favorite

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK

By Hoshino Y.   Jones R.W.   Chanock R.M.   Kapikian A.Z.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3576-3584

Elsevier

Access to resources Recommend Favorite

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response

By Wyeth-Ayerst ca Influenza Vaccine Study Group   Gruber W.C.   Darden P.M.   Still J.G.   Lohr J.   Reed G.   Wright P.F.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1379-1384

Elsevier

Access to resources Recommend Favorite

Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines

By Hoshino Y.   Jones R.W.   Ross J.   Kapikian A.Z.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 3003-3010

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite